Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M De Jonge

Showing results (41-50 of 158) with videos related to

Pageof 16
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 14, 2018
Pharmacodynamic modelling of β-lactam/β-lactamase inhibitor checkerboard data: illustration with aztreonam-avibactamA Chauzy, J Buyck, B L M de Jonge, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2009
Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI)B L M de Jonge, A Kutschke, M Uria-Nickelsen, et al.
Facts, Views & Vision in Obgyn|April 23, 2014
Identification of neonatal near miss by systematic screening for metabolic acidosis at birthA Bonnaerens, A Thaens, T Mesens, et al.
Journal of Applied Research in Intellectual Disabilities : JARID|January 10, 2026
The Language of Change Among Individuals With Mild Intellectual Disability or Borderline Intellectual Functioning: Client Responses to Therapist Motivational Interviewing SkillsLotte C F Gosens, Jannet M de Jonge, Robert Didden, et al.
Aging|February 17, 2010
Paradoxical down-regulation of p16 mRNA with advancing age in acute myeloid leukemiaHendrik J M de Jonge, Carolien M Woolthuis, Eveline S J M de Bont, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomyE. T. M. De Jonge, E. Viljoen, B. G. Lindeque, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2016
In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014)Wright W Nichols, Boudewijn L M de Jonge, Krystyna M Kazmierczak, et al.
Critical Reviews in Oncology/Hematology|March 21, 2007
ABC transporter expression in hematopoietic stem cells and the role in AML drug resistanceSusan D P W M de Jonge-Peeters, Folkert Kuipers, Elisabeth G E de Vries, et al.
European Journal of Clinical Nutrition|December 21, 2006
A rare mutation in AgRP, +79G>A, affects promoter activityM A Sözen, L H M de Jonge, F Greenway, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible <i>Enterobacterales</i> Collected as Part of a Global Surveillance Program, 2012 to 2017Krystyna M Kazmierczak, James A Karlowsky, Boudewijn L M de Jonge, et al.
Pageof 16

Showing results (41-50 of 158) with videos related to

Sort By:
Pageof 16
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 14, 2018
Pharmacodynamic modelling of β-lactam/β-lactamase inhibitor checkerboard data: illustration with aztreonam-avibactamA Chauzy, J Buyck, B L M de Jonge, et al.
Antimicrobial Agents and Chemotherapy|May 13, 2009
Pyrazolopyrimidinediones are selective agents for Helicobacter pylori that suppress growth through inhibition of glutamate racemase (MurI)B L M de Jonge, A Kutschke, M Uria-Nickelsen, et al.
Facts, Views & Vision in Obgyn|April 23, 2014
Identification of neonatal near miss by systematic screening for metabolic acidosis at birthA Bonnaerens, A Thaens, T Mesens, et al.
Journal of Applied Research in Intellectual Disabilities : JARID|January 10, 2026
The Language of Change Among Individuals With Mild Intellectual Disability or Borderline Intellectual Functioning: Client Responses to Therapist Motivational Interviewing SkillsLotte C F Gosens, Jannet M de Jonge, Robert Didden, et al.
Aging|February 17, 2010
Paradoxical down-regulation of p16 mRNA with advancing age in acute myeloid leukemiaHendrik J M de Jonge, Carolien M Woolthuis, Eveline S J M de Bont, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 10, 2001
The prognostic significance of p53, mdm2, c-erbB-2, cathepsin D, and thrombocytosis in stage IB cervical cancer treated by primary radical hysterectomyE. T. M. De Jonge, E. Viljoen, B. G. Lindeque, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2016
In Vitro Susceptibility of Global Surveillance Isolates of Pseudomonas aeruginosa to Ceftazidime-Avibactam (INFORM 2012 to 2014)Wright W Nichols, Boudewijn L M de Jonge, Krystyna M Kazmierczak, et al.
Critical Reviews in Oncology/Hematology|March 21, 2007
ABC transporter expression in hematopoietic stem cells and the role in AML drug resistanceSusan D P W M de Jonge-Peeters, Folkert Kuipers, Elisabeth G E de Vries, et al.
European Journal of Clinical Nutrition|December 21, 2006
A rare mutation in AgRP, +79G>A, affects promoter activityM A Sözen, L H M de Jonge, F Greenway, et al.
Antimicrobial Agents and Chemotherapy|May 11, 2021
Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible <i>Enterobacterales</i> Collected as Part of a Global Surveillance Program, 2012 to 2017Krystyna M Kazmierczak, James A Karlowsky, Boudewijn L M de Jonge, et al.
Pageof 16